Neurogen Corp. - Branford, Conn. 3rd Quar Sept. 30:
2000 1999
Revenue $7,250,000 $2,630,000
Net income a 697,000 (3,665,000)
Avg shrs (basic) 17,277,000 b 14,588,000
Avg shrs (diluted) 18,872,000 b 14,588,000
Shr earns (basic)
Net income a .04 b (.25)
Shr earns (diluted)
Net income a .04 b (.25)
Figures in parentheses are losses.
a. Includes $4.9 million in fees from Pfizer Inc. relating to a June 1999 licensing agreement.
b. Excludes contingently issuable common stock securities because they are anti-dilutive. |
